Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 2
2010 5
2011 7
2012 4
2013 6
2014 4
2015 4
2016 8
2017 14
2018 10
2019 11
2020 18
2021 25
2022 23
2023 27
2024 30
2025 23
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators. Wolff D, et al. Among authors: tian c. N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537. N Engl J Med. 2024. PMID: 39292927 Clinical Trial.
Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial.
Rao S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, Morano F, Roy A, Dahan L, Tamberi S, Dhadda AS, Saunders MP, Casanova N, Guimbaud R, Lievre A, Maurel J, Fakih M, Tian C, Harrison J, Jones MM, Cornfeld M, Spano JP, Rochefort P; POD1UM-303/InterAACT-2 study investigators. Rao S, et al. Among authors: tian c. Lancet. 2025 Jun 14;405(10495):2144-2152. doi: 10.1016/S0140-6736(25)00631-2. Lancet. 2025. PMID: 40517007 Free article. Clinical Trial.
A multi-omics molecular landscape of 30 tissues in aging female rhesus macaques.
Li GH, Zhu XQ, Xiao FH, Zhao X, Lv L, Yin FQ, Chang L, Ge MX, Wang Q, Zhao J, Tian C, Li Z, Ruan G, Pang R, Gao J, Ma L, Pan XH, Kong QP. Li GH, et al. Among authors: tian c. Nat Methods. 2025 Dec;22(12):2658-2669. doi: 10.1038/s41592-025-02912-y. Epub 2025 Nov 17. Nat Methods. 2025. PMID: 41249656
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).
Grignani G, Rutkowski P, Lebbé C, Guida M, Gaudy-Marqueste C, Spagnolo F, Burgess M, Morano F, Montaudié H, Depenni R, Spada F, Yeung CCS, Pulini J, Cornfeld M, Tian C, Bhatia S. Grignani G, et al. Among authors: tian c. J Immunother Cancer. 2025 Aug 11;13(8):e012478. doi: 10.1136/jitc-2025-012478. J Immunother Cancer. 2025. PMID: 40796223 Free PMC article. Clinical Trial.
Anticancer activities of natural abietic acid.
Ahmad B, Tian C, Tang JX, Dumbuya JS, Li W, Lu J. Ahmad B, et al. Among authors: tian c. Front Pharmacol. 2024 Apr 3;15:1392203. doi: 10.3389/fphar.2024.1392203. eCollection 2024. Front Pharmacol. 2024. PMID: 38633616 Free PMC article. Review.
205 results